demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
ivermectin Behera Ivercar-Tuc Behera Seet 2021 NCT04422561 ... Alam

3 studies excluded by filtering options 2

6097 Elgazzar - prophylaxis, 2020 213excludedhigh risk of bias
6374 NCT04425850 (Caravallo), 2020 2310excludednot a RCTrisk of bias not avaialble
10322 Elgazzar, 0 200excludedrisk of bias not avaialble